Donald E. Bobo Jr. - 09 Nov 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Nov 2026, 16:29:15 UTC
Prior SEC filing
27 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Linda J. Park, Attorney-in-Fact
Filing notes and source

Key filing fact

Donald E. Bobo Jr. filed Form 4 for Edwards Lifesciences Corp (EW) on 09 Nov 2026.

Key facts

  • This page summarizes Donald E. Bobo Jr.'s Form 4 filing for Edwards Lifesciences Corp (EW).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 09 Nov 2026, 16:29.

Change

  • Previous filing in this sequence was filed on 27 May 2026.
  • Current net transaction value: -$5,039,311.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001196661 Primary reporting owner

BOBO DONALD E JR

Relationship
CVP,Strategy/Corp Development
Address
ONE EDWARDS WAY, IRVINE
Signature
Linda J. Park, Attorney-in-Fact
Signature date
09 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Options Exercise

Transaction value
Shares
+48,900
Change %
+214%
Price
$72.68*
Shares after
71,698
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1
EW transaction

Common Stock

Sale

Transaction value
-$5,039,311
Shares
-48,900
Change %
-68%
Price
$103.05
Shares after
22,798
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1, F2
EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,970
Date
09 Nov 2026
Ownership
401(k)
EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
98,611
Date
09 Nov 2026
Ownership
By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EW transaction Derivative

Employee Stock Option (Right to Acquire)

Options Exercise

Transaction value
Shares
-48,900
Change %
-100%
Price
$0.000000*
Shares after
0
Date
09 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
48,900
Exercise price
$72.68
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2026.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $103.00 to $103.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .